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Mice with infectious colitis exhibit linear growth failure and 
subsequent catch-up growth related to systemic inflammation 
and IGF-1
Mark D. DeBoer, MD, MSc., MCR1,3,5, Vidhya Vijayakumar, Ph.D2,3, Meiqing Gong, BSc.2,3, 
John L. Fowlkes, MD4, Rachel M. Smith, MSc.2,3, Fernando Ruiz-Perez, Ph.D2,3, and James 
P. Nataro, MD, Ph.D.2,3
1Division of Pediatric Endocrinology, University of Virginia, Charlottesville, VA
2Division of Pediatric Infectious Disease, University of Virginia, Charlottesville, VA
3Department of Pediatrics, University of Virginia, Charlottesville, VA
4Barnstable Brown Diabetes Center and Division of Pediatric Endocrinology, Department of 
Pediatrics, University of Kentucky, Lexington, KY
Abstract
In developing communities, intestinal infection is associated with poor weight gain and linear-
growth failure. Prior translational animal models have focused on weight gain investigations into 
key contributors to linear growth failure have been lacking. We hypothesized that murine intestinal 
infection with Citrobacter-rodentium would induce linear-growth failure associated with systemic 
inflammation and suppressed serum levels of insulin-like growth factor-1 (IGF-1). We evaluated 4 
groups of mice infected or sham-infected on day-of-life 28: uninfected-controls, wild-type C.-
rodentium-infected, partially-attenuated C. rodentium-infected (with deletion of 3 serine protease 
genes involved in colonization), and pair-fed (given the amount of daily food consumed by the 
wild-type C.-rodentium group). Relative to the uninfected group, mice infected with wild-type C. 
rodentium exhibited temporal associations of lower food intake, weight loss, linear-growth failure, 
higher IL-6 and TNF-α and lower IGF-1. However, relative to the pair-fed group, the C.-
rodentium-infected group only differed significantly by linear growth and systemic inflammatory 
cytokines. Between post-infection days 15–20, the infected group exhibited resolution of systemic 
inflammation. Between days 16–20, both wild-type C.-rodentium and pair-fed groups exhibited 
rapid linear-growth velocities exceeding the uninfected and mutant C.-rodentium groups; during 
this time levels of IGF-1 increased to match the uninfected group. We submit this as a model 
providing important opportunities to study mechanisms of catch-up growth related to intestinal 
inflammation. We conclude that in addition to known effects of weight loss, infection with C. 
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rodentium induces linear-growth failure potentially related to systemic inflammation and low 
levels of IGF-1, with catch-up of linear growth following resolution of inflammation.
Keywords
diarrhea; Citrobacter rodendium; growth failure; inflammation; insulin-like growth factor-1
1. Introduction
Infectious diarrhea continues to affect children worldwide, with an estimated mortality of 
over 700,000 children yearly [1]. While diarrhea-related mortality has decreased over the 
past 20 years, morbidity persists, including nutritional deficits, and retardation of linear and 
ponderal growth [2]. The underlying mechanisms of poor linear growth in these settings 
remain unclear including whether the weight and height deficits are related to decreased 
food intake, systemic inflammation, poor absorption of nutrients, and dysregulation of 
systemic growth factors such as insulin-like growth factor (IGF)-1 [3, 4]. Persistent length/
height measurement of more than two standard deviations below the mean (i.e., stunting) 
affects many of these children, even after resolution of the intestinal infections [5, 6]. Other 
children exhibit compensatory catch-up growth, an accelerated growth velocity that partially 
or completely normalizes their height [7, 8]. To date, animal models have focused on weight 
loss, with few translational animal models to study these complex linear-growth-impacting 
phenomena [9].
One mouse model to study the sequelae of infectious diarrhea involves inoculation with 
Citrobacter rodentium [10]. While this bacterial strain is not a human pathogen, it features 
virulence factors similar to those of human diarrheagenic pathogens and mimics the effect of 
human infectious diarrhea, with prior studies demonstrating significant weight loss, though 
the effect on linear growth has not been assessed in detail [11]. The noted weight loss is 
potentially related to decreased food intake, poor absorption of nutrients or increased energy 
expenditure during infection [10, 11]. However, the pathophysiology related to any linear 
growth deficits in this model remains unclear.
The goal of the current studies is to evaluate and explore temporal relationships between 
weight gain, growth failure, and changes in serum levels of IGF-1 and systemic cytokines 
over the course of infection with C. rodentium. We hypothesize that mice infected with C. 
rodentium (relative to sham-infected mice and relative to pair-fed controls who are only 
given as much daily food as the infected mice had consumed) will exhibit poor linear growth 
related to systemic inflammation and lower levels of IGF-1. We further hypothesize that 
following clearance of their infection, growth-stunted mice will exhibit “catch-up” growth, 
to obtain lengths and weights consistent with those of the uninfected group. The results of 
these studies provide for a novel and translationally relevant animal model to study 
mechanisms of catch up growth following intestinal infection.
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2. Methods and materials
2.1 Animal care and infection
All animal studies were carried out in strict compliance with the recommendations in the 
Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The 
protocol was approved by the University of Virginia Animal Care and Use Committee 
(protocol number 3894). All efforts were made to keep pain and suffering to a minimum. All 
animals were fed Teklad LM-485 laboratory chow 7012, which contains a proprietary 
formulation composed of ground corn, dehulled soybean meal, ground oats, wheat 
middlings, dehydrated alfalpha meal, soybean oil, corn gluten meal, and mineral and vitamin 
premixes (Envigo, Huntingdon, UK). The proximate analysis of the diet is shown in Table 1. 
The C. rodentium model was used as described previously [12, 13]. Briefly, over multiple 
sets of experiments, 3- to 4-week-old, C57BL/6 mice were purchased from Jackson 
Laboratories (Bar Harbor, ME). Mice were divided into 4 groups: those infected with wild-
type C. rodentium, with a mutant strain of C. rodentium (with deletions of three serine 
protease autotransporters-encoding genes [crc1, crc2 and adca] involved in colonization and 
pathogenesis [12, 14]), an uninfected control group sham-treated with phosphate-buffered 
saline (PBS) at time of infection, and a group pair-fed the same food quantity as that 
consumed by the wild-type C. rodentium mice. We included the mutant strain of C. 
rodentium because this strain had been demonstrated to induce less severe colitis compared 
to that seen following inoculation with wild-type C. rodentium (unpublished observations). 
This permitted analysis of whether any growth-related sequelae persisted even in the absence 
of fulminant disease.
On day of life 28 or 29, mice from the infected groups were inoculated with approximately 
1010 colony-forming units (CFU) of wild type C. rodentium ICC-180 or with the isogenic 
mutant strain described above. The bacterial inoculum was suspended in 200 uL of PBS and 
administered by oral gavage using a 20-gauge intubation needle. Control animals received 
200 uL of sterile PBS. Efficacy of infection was assessed by culture; fecal pellets were 
collected aseptically from each infected mouse, weighed, and emulsified in PBS. The 
number of viable CFU of C. rodentium bacteria per gram of feces was determined by plating 
serial dilutions of the samples on medium containing appropriate selective antibiotics [12]. 
Similarly, separate groups of mice were euthanized by anesthesia and cervical dislocation 
and had their colons removed for analysis of colonization. For enumeration of bacteria in the 
distal colon, a 2- to 3-cm section of the distal colon was excised. Lumenal contents were 
expelled and the colon segment was opened and rinsed thoroughly in PBS to remove fecal 
material, homogenized in 1 ml PBS with a Handi-Shear tissue homogenizer (VirTis, 
Gardiner, NY), and diluted in PBS for plating on MacConkey agar. Finally, for assessment 
of stool quality over time, at specified time points after inoculation, fecal pellets were 
evaluated for stool consistency (categorized as solid, solid/soft, soft, watery) and for the 
presence of mucus or blood. At the experiment’s end (following blood draw, if applicable), 
animals were euthanized via cervical dislocation under anesthesia.
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2.2 Anthropometry measurements
Weight was measured every-other-day using a digital scale (Tanita Corp., Arlingtron 
Heights, IL). Length measurements were performed every 4 days under sedation with 
isoflurane using a vaporizer (LEI Medical, Portland, OR) and digital calipers (Fisher 
Scientific, Waltham, MA)[15]. All measurements were performed twice; a third 
measurement was performed if these measures were greater than 5% different from each 
other; the average of these measurements was then used. All length measurements were 
performed by a single investigator (MDD). Nose-anus measurements were made with the 
animal supine with gentle pressure to extend the neck, measuring from the furthest point on 
the animal’s nose to the furthest point on the anus. Length measurements were performed 
with the investigator blinded to the treatment group for the first group of mice (N=10 at 
baseline for each group). Blinding was not possible for subsequent sets of animals (N=10 for 
each group). However, measurements were compared between experiments and were not 
significantly different between sets within each group; therefore, data were combined for 
anthropometry measurements for each set of experiments.
2.3 Pair-feeding
Mice were stored in wire-rack cages with chow placed on the wire rack. Food intake was 
followed daily by weighing the food on the wire rack plus any portion that had fallen 
through, and subtracting from the previous day’s food weight. For all groups except the pair-
fed group, this daily amount of food consumed was divided by the number of animals in the 
cage (up to 5 animals). Pair-fed animals were individually-housed and each pair-fed mouse 
was given only enough food to match the previous day’s average per-mouse consumption by 
wild-type C. rodentium-infected animals. For pair-fed animals, food that was unconsumed 
by an individual mouse at the end of the 24-hour period (an occurrence only noted on days 
17–20 post-infection) was weighed and provided to that animal again, in addition to that 
day’s food allotment. For calculating total food intake, this unconsumed food portion was 
subtracted from what had been provided to the animal the previous day.
2.4 Serum measurements
For assessment of cytokines and IGF-1, serum was drawn via cardiac puncture under 
anesthesia from separate cohorts of animals at time of euthanizing on days 3, 7 and 10 after 
infection. An additional cohort of animals had live blood draw via facial vein under 
anesthesia performed at 15 days after infection via ophthalmic artery puncture for each 
treatment group and then terminal blood draw at day 20. We measured levels of serum 
cytokines to assess pro-inflammatory (IL-6 and TNF-α), anti-inflammatory (IL-10) and 
adaptive-immune-modulatory (INF-γ) cytokine responses during infection with C. 
rodentium. Quantification of serum cytokines was performed by the University of Virginia 
Immunology core using Milliplex Mouse Cytokine/Chemokine Panel 1 Assay 
(MilliporeSigma, Billerica, MA). Assays were performed according to the manufacturer’s 
specifications and analyzed with a Luminex MagPix platform (Luminex Corp., Austin, TX). 
Fluorescence intensity from duplicate samples was averaged and transformed into protein 
concentration using a calibration curve obtained from recombinant cytokine standards 
analyzed with Milliplex Analyst 5.1 software (MilliporeSigma, St. Louis, MO). Serum 
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IGF-1 measurement was performed on mouse serum using ELISA (IDS, Tyne & Wear, UK 
and Crystal Chem, Downers Grove, IL) according to the manufacturers’ instructions.
2.5 Statistical Analysis
We assessed data for normality using Excel (Microsoft, Seattle, WA) and Prizm (Graphpad, 
San Diego, CA) and log-transformed data for statistical comparison when not normally 
distributed (e.g. for serum levels of cytokines). Data are reported as means and standard 
error of the mean (SEM). Our primary outcome of interest was difference in length between 
the mice infected with wild-type C. rodentium and the pair-fed group. This comparison was 
performed using t-tests in Prizm. All other comparisons between groups were performed 
using analysis of variance (ANOVA) in Prizm. Because of uncertain mortality among treated 
mice, we began with n=20 per group for wild-type C. rodentium, mutant C. rodentium and 
pair-fed mice and n=15 for uninfected controls. While we lacked prior variance data to 
perform a priori power calculations for the study, given the observed variance in each group 
and the number of mice surviving the experiment, we had 80% power to detect a difference 
of as little as 0.75-standard deviation (approximately 2% of body length) between the mice 
infected with wild-type and the pair-fed group. Statistical significance was considered for 
p<0.05. Mice that died before the end of the experiment were included in calculation of 
mortality by treatment group but were excluded from calculation of daily weight, length and 
food intake by group. Statistical comparison of food consumption amounts between groups 
(as well as calculation of SEM) was not valid because all mice who were not in the pair-fed 
group had per-mouse quantities calculated for each cage (minimizing the true variation in 
food consumption on an individual mouse basis), while pair-fed animals were all fed 
identical amounts of the average food consumed by the wild-type C-rodentium mice on a 
daily basis.
3. Results
3.1 Infection efficacy and mortality
Figure 1 shows C. rodentium shedding in stool and colonization in colon of mice following 
inoculation with wild-type C. rodentium or mutant C. rodentium. Inoculation resulted in a 
high infection efficiency with both wild-type C. rodentium and mutant C. rodentium, with 
bacterial shedding that continued above 108 CFA/gr feces, continuing until at least 14 days 
after infection. Colonization was higher in mice infected with mice inoculated with wild-
type C. rodentium compared to mutant C. rodentium by day 10 after inoculation.
Table 2 shows stool consistency and the presence of mucus and/or blood for each of the 
treatment groups. Uninfected and pair-fed mice maintained solid stool throughout, while 
mice infected with wild-type C. rodentium all had affected stools (soft or watery) on days 
days 4 and 7 (both p<0.01 vs. uninfected), with all mice exhibiting blood or mucus in stool 
by day 7. Mice infected with mutant C. rodentium had a lower degree of soft stools by day 4 
(20% soft) and day 7 (60% solid/soft) and did not have blood or mucus.
Mortality was significant among mice with wild-type C. rodentium infection, with 8% by 10 
days and 32% by 15 days. One mouse from the mutant C. rodentium group died within 12 
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hours of inoculation, leaving a total mortality of 4% for this group. There was one pair-fed 
mouse (5%) that died at day 11 of unknown cause. There was no mortality among 
uninfected mice.
3.2 Weight gain, linear growth and food intake
Figure 2 shows food intake, weight gain, and length measures by treatment group. Food 
intake was relatively stable among uninfected mice and those infected with mutant C. 
rodentium (Figure 2A). Mice infected with wild-type C. rodentium exhibited a decrease in 
food intake starting day 7 after infection, with a nadir 10 days after infection, followed by a 
gradual increase in food intake above that of the uninfected animals by day 14 after 
infection. By design, food consumed by the pair-fed group matched the amount of food 
consumed by the wild-type C. rodentium group but with a 1-day delay in receiving this 
quantity.
Regarding weight gain, uninfected mice exhibited steady weight gain through the 
experiments (Figure 2B). Mice infected with wild-type C. rodentium exhibited a steady 
decrease in weight starting 4 days after infection, with a nadir at 13 days. These levels 
differed from uninfected mice on days starting at day 5 after infection (ANOVA p<0.05 on 
day 5 and p<0.001 thereafter). Mice that were pair-fed the same amount of food as those 
with wild-type C. rodentium had weights that were higher than the C. rodentium group until 
day 9 (p<0.05); at that point they began losing weight, experiencing a deeper (though not 
significantly lower) nadir and more rapid re-gain of weight than seen for the wild-type C. 
rodentium this group, with a higher weight on day 17 (p<0.05). Pair-fed mice had weights 
that were significantly different from uninfected mice on days 11–15 after infection 
(p<0.001) and were different from mice infected with mutant C. rodentium on days 11–15 
after infection (p<0.001 for days 11–13 and p<0.05 on day 15). Finally, mice infected with a 
mutant strain of C. rodentium exhibited weight gain intermediate between that of the 
uninfected (p<0.05 for days 5–17) and wild-type C. rodentium strain (p<0.01 day 11, 
p<0.001 days 13–17, and p<0.05 day 19), without frank weight loss but with slower weight 
gain. During the time from day 15 to 19, both the wild-type C. rodentium and pair-fed 
groups gained weight faster than the uninfected group (p<0.001) and mutant C. rodentium 
group (p<0.01).
Regarding linear growth, mice in the uninfected and mutant C. rodentium groups exhibited 
steady linear growth (Figure 2C). Length among mice infected with wild-type C. rodentium 
plateaued by day 4 after infection and nose-anus length remained lower than uninfected 
mice thereafter (p<0.01 on days 12–16) and lower than pair-fed mice days 12–16 after 
infection (p<0.05). Mice that were pair-fed the same amount of food as those with wild-type 
C. rodentium exhibited some slowing of linear growth after on day 4 but were not 
significantly different than the uninfected mice thereafter. Again, mice infected with a 
mutant strain of C. rodentium exhibited linear growth intermediate between that of the 
uninfected and wild-type C. rodentium strain that was different from wild-type C. rodentium 
at days 12 and 16 (p<0.01). Both the wild-type C. rodentium and the pair-fed mice appeared 
to exhibit particularly brisk “catch-up growth” between days 16–20, when interval growth 
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for both the wild-type C. rodentium (p<0.001) and pair-fed (p<0.05) groups was greater than 
the uninfected and triple mutant groups.
3.3 Cytokines
Levels of systemic cytokines over the course of the experiment are displayed in Figure 3. 
Relative to the uninfected group, mice infected with wild-type C. rodentium exhibited an 
increase in levels of IL-6 and TNF-α starting 3 days after infection (for both IL-6 and TNF-
α p<0.001 on day 15 after infection compared to all other groups). Mice in the pair-fed 
group had levels similar to the uninfected group, while mice infected with mutant C. 
rodentium displayed intermediate levels.
3.4 IGF-1 levels
IGF-1 levels over the course of the experiment are shown in Figure 4. Mice in the uninfected 
group exhibited a gradual increase in IGF-1 levels over time. By contrast, mice infected with 
wild-type C. rodentium experienced a decrease in IGF-1 levels, with a nadir at day 10 
(ANOVA compared to uninfected group p<0.001 days 7–15; lower than the pair-fed group at 
day 10, p<0.01). Subsequently there was a rise in IGF-1 levels above those of the uninfected 
group. Mice in the pair-fed group exhibited a later nadir in IGF-1 levels to the point where 
these were significantly below those of the uninfected group on days 7 and 15 after infection 
(p<0.01 and p<0.001, respectively), and also exhibited an dramatic increase by day 20. 
Again, mice infected with mutant C. rodentium had IGF-1 levels that were intermediate 
between wild-type C. rodentium and uninfected mice and were significantly different from 
wild-type C. rodentium at days 7–15 (p<0.001) and different from the pair-fed group on 
days 7 (p<0.05) and 15 (p<0.001).
4. Discussion
While weight loss during infection with C. rodentium has been previously characterized, we 
have expanded assessment of the model to reveal linear growth failure during infection, 
followed by subsequent “catch-up” growth that outpaces the growth of uninfected animals. 
In this sense, we accepted our research hypothesis that mice infected with C. rodentium 
would exhibit linear growth failure. While weight loss in this model have been investigated 
[10], this is the first in-depth look into potential contributors to linear growth failure. The 
linear growth characteristics are similar to what is frequently seen children in developing 
areas worldwide, who frequently experience intestinal infections and have related shortfalls 
in linear growth [5] and for whom predictors of catch-up growth have remained elusive [9]. 
This model may serve as a novel means of assessing mechanisms of linear growth 
suppression and subsequent acceleration during onset and clearance of intestinal infections. 
These data may thus have significance for testing optimal interventions to improve growth in 
the setting of recurrent infections.
In this model, we were particularly interested in the relationships between nutrition, 
inflammation and growth. Poor weight gain in this setting was most strongly associated with 
a sharp decrease in food intake among infected animals. Mice infected with wild-type C. 
rodentium responded to infection with a decrease in food consumption and had a similar 
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drop in weight as mice that were pair-fed the same amount of food as was consumed by the 
infected group. This apparent decrease in appetite has been noted previously in models of C. 
rodentium infection [16], though in evaluating growth responses to infection between 
infected and pair-fed groups, other investigators have assessed weight gain alone and not 
linear growth [17, 18].
In the current set of experiments, linear growth did not appear to be as tightly associated 
with nutrition. For instance, animals in the infected group exhibited a more significant linear 
growth faltering than those in the pair-fed group. While these observations are novel in the 
setting of C. rodentium infection, prior models of intestinal inflammation, such as following 
administration of trinitrobenzene sulfonic acid (TNBS), have also reported a greater degree 
of linear growth deficits among treated animals compared to pair-fed animals [19]. Animals 
with TNBS colitis given gavage feeding to deliver the same amount of calories consumed by 
the control group showed increases in weight gain, yet linear growth remained partially 
suppressed [19]. This suggested influences beyond the delivery of calories alone. Growth 
deficits not explained by nutrition alone have been proposed to result predominantly from 
inflammation [19, 20, 21, 22, 23, 24] or from suppression of growth factors in the setting of 
inflammation [25, 26].
With respect to the suppression of growth factors in our model, we noted lower levels of 
IGF-1 among mice infected with wild-type C. rodentium relative to the uninfected group at 
multiple time points and relative to the pair-fed group at day 10. Suppressed levels of IGF-1 
have been noted in both states of malnutrition [4, 27, 28] and systemic inflammation [26, 29, 
30]. In both of these scenarios, the low levels of IGF-1 appeared to result from growth 
hormone resistance at the level of the liver [28, 29, 30, 31, 32].
The mechanism for IGF-1 suppression among wild-type C. rodentium-infected animals in 
our model may be related to both inflammation and low food intake, given that 1) IGF-1 
levels were initially lower in infected compared to pair-fed animals, 2) by day 15, infected 
and pair-fed animals later had similar levels of IGF-1 and 3) by day 20, infected and pair-fed 
animals had similar recovery (in fact, above levels seen among uninfected animals). Thus, 
whereas IGF-1 did not appear to play a central role in growth suppression in the later stages 
of infection and recovery, the role of IGF-1 in the initial suppression of growth in this model 
requires further evaluation. Furthermore, assessment for resistance to IGF-1 in the tissue is 
also warranted in this setting [33, 34].
With respect to systemic inflammation, however, there was a clear separation among the 
treatment groups, with levels of IL-6 that were elevated by day 3 after infection and 
remained elevated up to day 15. Levels of cytokines did not normalize until day 20 after 
infection, and this normalization was associated with a rapid increase in linear growth. This 
increase in linear growth was not seen in the pair-fed group, who exhibited low levels of the 
systemic inflammatory cytokines IL-6 and TNF-α. In this way, it appeared that the linear 
growth suppression among C. rodentium-infected mice was most strongly associated with 
these elevations in systemic inflammation. Clearly, more definitive investigations are needed 
to identify whether this suppression relates to direct effects of inflammatory and/or other 
cytokines at the growth plate itself or through other mechanisms [34, 35].
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Our data suggest that catchup growth relates to both increased appetite and increased 
physiologic anabolic response to caloric intake. If these phenomena prevail as well in 
children, it would suggest the importance of assuring additional calories in the wake of an 
inflammatory infection. One important consideration regarding growth suppression in 
developing areas of the world is whether the growth deficits in early childhood: 1) are 
permanent, resulting in short adult height 2) will result in a delayed cessation of growth, 
resulting in normal adult height or 3) will resolve during early childhood, resulting in catch-
up growth that normalizes (or partially normalizes) height. Catch-up growth is recognized as 
an important process for children who have experienced growth suppression in early 
childhood [9]. Catch-up growth has been described as “a height velocity above the statistical 
limits of normality for age or maturity during a defined period of time, following a transient 
period of growth inhibition; the effect of catch-up growth is to take the child towards his/her 
pre-retardation growth curve [8].” However, the predictors and mechanisms of catch-up 
growth remain poorly understood [9], and animal models are needed to assess whether 
catch-up growth is related to hormonal changes or to changes at the level of the growth 
plate, including a delay in senescence and increased proliferation of cells at the growth plate 
[9, 36]. Further research is needed in disease states involving mixed processes of 
inflammation and nutrition deficits to determine if catch-up growth is more strongly related 
to resolution of one process over the other. We submit that the model of catch-up growth 
following infection with C. rodentium represents a model of intestinal infection that could be 
used to assess these underpinnings of catch-up growth.
Mice infected with wild-type C. rodentium had a much more severe growth response than 
mice infected with a mutant strain of C. rodentium. This mutant strain was deficient in 3 
genes that belong to the serine protease autotransporters of Enterobacteriaceae (SPATEs)[12, 
14]. These genes appear to be important for colonization and pathogenesis, potentially 
accounting for the decrease in virulence of this strain and the relative preservation of weight 
gain and linear growth, though this remains to be further characterized. Clearly, the data in 
these experiments are observational in nature; continued work using this model will be 
needed to determine the exact mechanisms of growth suppression in these settings. For 
example, we lacked data regarding shedding and intestinal colonization up to day 20 post-
infection as well as data linking the degree of shedding and colonization to the degree of 
growth failure and were thus unable to determine the exact role of on-going infection and 
recovery on subsequent catch-up growth. Multiple other questions of pathogen-specific 
mechanism remain. C. rodentium is an attaching and effacing pathogen, similar to 
enteropathogenic E. coli (EPEC). Further experiments are required to determine whether this 
degree of growth failure might be associated with other pathogens, including 
Campylobacter, Cryptosporidium and enteroaggerative E. coli—and whether the growth 
failure is directly related to the virulence of the organism. Assessment of intestinal 
colonization using RT-PCR would improve sensitivity and specificity of detection of the 
type of microorganism involved. Finally, further research regarding intestinal infectious 
models should also be focused on the relationship between intestinal barrier function, 
classical intestinal morphology, local inflammatory biomarkers and linear growth failure.
This study also had several methodological limitations. Animal length was measured in all 
animals using general anesthesia to provide the opportunity to have repeated measures in 
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each animal over the course of treatment, (as has been described previously [19, 37]); any 
effect of this on the animal is not clear but would have been expected to affect all animals 
equally. While the measurements we used are customary, they examine the axial skeleton 
only. Femur length would be the best surrogate measure to examine the appendicular 
skeleton. We only followed animals for 20 days after infection, to an absolute age of 48–49 
days. This is a time point when mice are growing at a noticeable rate. Nevertheless, the 
importance of catch-up growth (or the lack thereof) relates most to whether adult height is 
preserved. This requires longer follow-up time and may be problematic in rodents, in whom 
growth plates do not reach complete fusion as seen in humans. Further assessment will be 
needed to assess whether mice infected with C. rodentium reach a similar near-final length 
as uninfected animals.
In conclusion, we found that infection with wild type C. rodentium resulted in poor weight 
gain and linear growth failure—similar to growth patterns observed in early childhood in 
developing areas of the world where enteral infections are endemic. In this model, infection 
was associated with low levels of IGF-1, similar to food-restricted animals. Overall, growth 
suppression was most closely linked to elevations in systemic inflammatory cytokines. More 
investigations using this model are needed to further determine specific mechanisms 
suppressing growth during intestinal infection.
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Abbreviation list
CFU colony-forming units
INF-γ interferon-γ
IL-6 interleukin-6
IL-10 interleukin-10
IGF-1 insulin-like growth factor-1
PBS phosphate-buffered saline
TNBS trinitrobenzene sulfonic acid
TNF-α tumor necrosis factor-α
DeBoer et al. Page 10
Nutr Res. Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
References
1. Walker CL, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA, O’Brien KL, Campbell H, Black 
RE. Global burden of childhood pneumonia and diarrhoea. Lancet. 2013; 381:1405–16. [PubMed: 
23582727] 
2. Black RE, Allen LH, Bhutta ZA, Caulfield LE, de Onis M, Ezzati M, Mathers C, Rivera J. Maternal 
and child undernutrition: global and regional exposures and health consequences. Lancet. 2008; 
371:243–60. [PubMed: 18207566] 
3. Jones AD, Rukobo S, Chasekwa B, Mutasa K, Ntozini R, Mbuya MN, Stoltzfus RJ, Humphrey JH, 
Prendergast AJ. Acute illness is associated with suppression of the growth hormone axis in 
Zimbabwean infants. Am J Trop Med Hyg. 2015; 92:463–70. [PubMed: 25535308] 
4. Bartz S, Mody A, Hornik C, Bain J, Muehlbauer M, Kiyimba T, Kiboneka E, Stevens R, Bartlett J, 
St Peter JV, Newgard CB, Freemark M. Severe acute malnutrition in childhood: hormonal and 
metabolic status at presentation, response to treatment, and predictors of mortality. J Clin 
Endocrinol Metab. 2014; 99:2128–37. [PubMed: 24606092] 
5. Checkley W, Buckley G, Gilman RH, Assis AM, Guerrant RL, Morris SS, Molbak K, Valentiner-
Branth P, Lanata CF, Black RE. Multi-country analysis of the effects of diarrhoea on childhood 
stunting. Int J Epidemiol. 2008; 37:816–30. [PubMed: 18567626] 
6. DeBoer MD, Scharf RJ, Leite AM, Férrer A, Havt A, Pinkerton R, Lima AA, Guerrant RL. 
Systemic inflammation, growth factors, and linear growth in the setting of infection and 
malnutrition. Nutrition. 2017; 33:248–53. [PubMed: 27712965] 
7. Richard SA, Black RE, Gilman RH, Guerrant RL, Kang G, Lanata CF, Mølbak K, Rasmussen ZA, 
Sack RB, Valentiner-Branth P, Checkley W. Network CMaI. Catch-up growth occurs after diarrhea 
in early childhood. J Nutr. 2014; 144:965–71. [PubMed: 24699805] 
8. Boersma B, Wit JM. Catch-up growth. Endocr Rev. 1997; 18:646–61. [PubMed: 9331546] 
9. de Wit CC, Sas TC, Wit JM, Cutfield WS. Patterns of catch-up growth. J Pediatr. 2013; 162:415–20. 
[PubMed: 23153864] 
10. Collins JW, Keeney KM, Crepin VF, Rathinam VA, Fitzgerald KA, Finlay BB, Frankel G. 
Citrobacter rodentium: infection, inflammation and the microbiota. Nat Rev Microbiol. 2014; 
12:612–23. [PubMed: 25088150] 
11. Borenshtein D, Fry RC, Groff EB, Nambiar PR, Carey VJ, Fox JG, Schauer DB. Diarrhea as a 
cause of mortality in a mouse model of infectious colitis. Genome Biol. 2008; 9:R122. [PubMed: 
18680595] 
12. Vijayakumar V, Santiago A, Smith R, Smith M, Robins-Browne RM, Nataro JP, Ruiz-Perez F. Role 
of class 1 serine protease autotransporter in the pathogenesis of Citrobacter rodentium colitis. 
Infect Immun. 2014; 82:2626–36. [PubMed: 24711562] 
13. Hart E, Yang J, Tauschek M, Kelly M, Wakefield MJ, Frankel G, Hartland EL, Robins-Browne 
RM. RegA, an AraC-like protein, is a global transcriptional regulator that controls virulence gene 
expression in Citrobacter rodentium. Infect Immun. 2008; 76:5247–56. [PubMed: 18765720] 
14. Ruiz-Perez F, Nataro JP. Bacterial serine proteases secreted by the autotransporter pathway: 
classification, specificity, and role in virulence. Cell Mol Life Sci. 2014; 71:745–70. [PubMed: 
23689588] 
15. Sundstrom J, Sullivan L, D’Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric 
acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005; 
45:28–33. [PubMed: 15569852] 
16. Li L, Shi QG, Lin F, Liang YG, Sun LJ, Mu JS, Wang YG, Su HB, Xu B, Ji CC, Huang HH, Li K, 
Wang HF. Cytokine IL-6 is required in Citrobacter rodentium infection-induced intestinal Th17 
responses and promotes IL-22 expression in inflammatory bowel disease. Mol Med Rep. 2014; 
9:831–6. [PubMed: 24430732] 
17. Nyagode BA, Lee CM, Morgan ET. Modulation of hepatic cytochrome P450s by Citrobacter 
rodentium infection in interleukin-6- and interferon-{gamma}-null mice. J Pharmacol Exp Ther. 
2010; 335:480–8. [PubMed: 20719939] 
18. Richardson TA, Sherman M, Antonovic L, Kardar SS, Strobel HW, Kalman D, Morgan ET. 
Hepatic and renal cytochrome p450 gene regulation during citrobacter rodentium infection in wild-
DeBoer et al. Page 11
Nutr Res. Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
type and toll-like receptor 4 mutant mice. Drug Metab Dispos. 2006; 34:354–60. [PubMed: 
16339354] 
19. Ballinger AB, Azooz O, El-Haj T, Poole S, Farthing MJ. Growth failure occurs through a decrease 
in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut. 
2000; 46:694–700. [PubMed: 10764714] 
20. Ballinger AB, Camacho-Hubner C, Croft NM. Growth failure and intestinal inflammation. Qjm. 
2001; 94:121–5. [PubMed: 11259686] 
21. DeBoer MD, Li Y, Cohn S. Colitis causes delay in puberty in female mice out of proportion to 
changes in leptin and corticosterone. J Gastroenterol. 2010; 45:277–84. [PubMed: 20072791] 
22. DeBoer MD, Li Y. Puberty is delayed in male mice with dextran sodium sulfate colitis out of 
proportion to changes in food intake, body weight, and serum levels of leptin. Pediatr Res. 2011; 
69:34–9. [PubMed: 20940665] 
23. DeBoer MD, Steinman J, Li Y. Partial normalization of pubertal timing in female mice with DSS 
colitis treated with anti-TNF-α antibody. J Gastroenterol. 2012; 47:647–54. [PubMed: 22322660] 
24. DeBoer MD, Denson LA. Delays in puberty, growth, and accrual of bone mineral density in 
pediatric Crohn’s disease: despite temporal changes in disease severity, the need for monitoring 
remains. J Pediatr. 2013; 163:17–22. [PubMed: 23522861] 
25. Gupta N, Lustig RH, Kohn MA, McCracken M, Vittinghoff E. Sex differences in statural growth 
impairment in Crohn’s disease: role of IGF-1. Inflamm Bowel Dis. 2011; 17:2318–25. [PubMed: 
21287667] 
26. De Benedetti F, Alonzi T, Moretta A, Lazzaro D, Costa P, Poli V, Martini A, Ciliberto G, Fattori E. 
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like 
growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest. 
1997; 99:643–50. [PubMed: 9045866] 
27. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth 
factors. Endocr Rev. 1994; 15:80–101. [PubMed: 8156941] 
28. Scacchi M, Pincelli AI, Cavagnini F. Nutritional status in the neuroendocrine control of growth 
hormone secretion: the model of anorexia nervosa. Front Neuroendocrinol. 2003; 24:200–24. 
[PubMed: 14596812] 
29. DiFedele LM, He J, Bonkowski EL, Han X, Held MA, Bohan A, Menon RK, Denson LA. Tumor 
necrosis factor alpha blockade restores growth hormone signaling in murine colitis. 
Gastroenterology. 2005; 128:1278–91. [PubMed: 15887111] 
30. Fan J, Li YH, Bagby GJ, Lang CH. Modulation of inflammation-induced changes in insulin-like 
growth factor (IGF)-I and IGF binding protein-1 by anti-TNF antibody. Shock. 1995; 4:21–6. 
[PubMed: 7552773] 
31. Denson LA, Held MA, Menon RK, Frank SJ, Parlow AF, Arnold DL. Interleukin-6 inhibits hepatic 
growth hormone signaling via upregulation of Cis and Socs-3. Am J Physiol Gastrointest Liver 
Physiol. 2003; 284:G646–54. [PubMed: 12519742] 
32. Denson LA, Menon RK, Shaufl A, Bajwa HS, Williams CR, Karpen SJ. TNF-alpha downregulates 
murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 binding. The 
Journal of Clinical Investigation. 2001; 107:1451–8. [PubMed: 11390427] 
33. Jain S, Golde DW, Bailey R, Geffner ME. Insulin-like growth factor-I resistance. Endocr Rev. 
1998; 19:625–46. [PubMed: 9793761] 
34. Wong SC, Dobie R, Altowati MA, Werther GA, Farquharson C, Ahmed SF. Growth and the 
Growth Hormone-Insulin Like Growth Factor 1 Axis in Children With Chronic Inflammation: 
Current Evidence, Gaps in Knowledge, and Future Directions. Endocr Rev. 2016; 37:62–110. 
[PubMed: 26720129] 
35. MacRae VE, Farquharson C, Ahmed SF. The restricted potential for recovery of growth plate 
chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines. J 
Endocrinol. 2006; 189:319–28. [PubMed: 16648299] 
36. Baron J, Klein KO, Yanovski JA, Novosad JA, Bacher JD, Bolander ME, Cutler GB. Induction of 
growth plate cartilage ossification by basic fibroblast growth factor. Endocrinology. 1994; 
135:2790–3. [PubMed: 7988472] 
DeBoer et al. Page 12
Nutr Res. Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
37. Sundström K, Cedervall T, Ohlsson C, Camacho-Hübner C, Sävendahl L. Combined treatment 
with GH and IGF-I: additive effect on cortical bone mass but not on linear bone growth in female 
rats. Endocrinology. 2014; 155:4798–807. [PubMed: 25243853] 
DeBoer et al. Page 13
Nutr Res. Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. C. rodentium bacterial shedding and colonization following infection
Values are means (+/− SEM) colony forming units (CFU) of C. rodentium bacteria per gram 
of stool (A, shedding data) or per gram of colon (B, colonization data) following inoculation 
with wild type C. rodentium or mutant C. rodentium. § p<0.05 vs. mutant C. rodentium; §§ 
p<0.001 vs. mutant C. rodentium
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Figure 2. Food intake, weight gain and linear growth measures over the course of experiment
Values are means (+/− SEM) by treatment group for animals infected with wild type 
Citrobacter rodentium, mutant C. rodentium, uninfected, and pair-fed groups: A. daily food 
intake. B. weight; C. length, nose-to-anus. Significance between groups: * p<0.05 vs. 
uninfected; ** p<0.01 vs. uninfected; § p<0.05 vs. mutant C. rodentium; §§ p<0.01 vs. 
mutant C. rodentium † p<0.05 vs. pair-fed.
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Figure 3. Serum cytokine levels over the course of experiment
Values are means (+/− SEM) by treatment group for animals infected with wild type 
Citrobacter rodentium, mutant C. rodentium, uninfected, and pair-fed groups (see text for 
details): A. IL-6; B. TNF-α; C. IL-10; D. interferon γ. All units are in pg/mL. Significance 
between groups: * p<0.001 vs. uninfected; § p<0.001 vs. mutant C. rodentium; † p<0.001 
vs. pair-fed.
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Figure 4. Serum IGF-1 levels over the course of experiment
Means (+/− SEM) of IGF-1 by treatment group for animals infected with wild type 
Citrobacter rodentium, mutant C. rodentium, uninfected, and pair-fed groups. Statistical 
significance between groups: * p<0.01 vs. uninfected; ** p<0.001 vs. uninfected; § p<0.05 
vs. mutant C. rodentium; §§ p<0.001 vs. mutant C. rodentium; † p<0.01 vs. pair-fed.
DeBoer et al. Page 17
Nutr Res. Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
DeBoer et al. Page 18
Ta
bl
e 
1
Co
m
po
sit
io
n 
of
 T
ek
la
d 
LM
-4
85
 la
bo
ra
to
ry
 ch
ow
 fe
d 
to
 m
ic
e.
Cr
ud
e 
pr
ot
ei
n 
(%
)
19
.1
Fa
t (
%)
5.
8
Ca
rb
oh
yd
ra
te
 (%
)
44
.3
Cr
ud
e 
fib
er
 (%
)
4.
6
En
er
gy
 d
en
sit
y 
(kc
al/
g)
3.
1
Ca
lo
rie
s f
ro
m
 p
ro
te
in
 (%
)
25
Ca
lo
rie
s f
ro
m
 fa
t (
%)
17
Ca
lo
rie
s f
ro
m
 c
ar
bo
hy
dr
at
e 
(%
)
58
Th
e 
m
ajo
r in
gre
die
nts
 of
 th
is 
die
t a
re 
de
scr
ibe
d i
n t
he
 m
eth
od
s a
nd
 m
ate
ria
ls 
sec
tio
n.
Nutr Res. Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
DeBoer et al. Page 19
Ta
bl
e 
2
St
oo
l c
on
sis
te
nc
y 
an
d 
pr
es
en
ce
 o
f b
lo
od
 a
nd
 m
uc
us
 in
 m
ic
e
U
ni
nf
ec
te
d
Pa
ir-
fe
d
W
ild
 ty
pe
 C
. r
od
en
tiu
m
M
ut
an
t C
. r
od
en
tiu
m
D
ay
 4
St
oo
l c
on
sis
te
nc
y 
(p
er
ce
n
t o
f m
ic
e)
 
So
lid
10
0
10
0
0
80
 
So
ft/
so
lid
0
0
0
0
 
So
ft
0
0
80
20
 
W
at
er
y
0
0
20
0
Bl
oo
d 
or
 m
uc
us
 p
re
se
n
t (
pe
rc
en
t o
f m
ic
e)
 
B
lo
od
y
0
0
0
0
 
M
uc
us
0
0
20
0
D
ay
 1
0
St
oo
l c
on
sis
te
nc
y 
(p
er
ce
n
t o
f m
ic
e)
 
So
lid
10
0
10
0
0
0
 
So
ft/
so
lid
0
0
0
60
 
So
ft
0
0
60
40
 
W
at
er
y
0
0
40
0
Bl
oo
d 
or
 m
uc
us
 p
re
se
n
t (
pe
rc
en
t o
f m
ic
e)
 
B
lo
od
y
0
0
60
0
 
M
uc
us
0
0
40
0
*
Va
lu
es
 a
re
 p
er
ce
nt
ag
es
 b
as
ed
 o
n 
n=
10
 m
ic
e 
pe
r g
ro
up
, w
ith
 th
e 
ex
ce
pt
io
n 
of
 d
ay
 1
0 
w
ild
 ty
pe
 C
. r
od
en
tiu
m
,
 
ba
se
d 
on
 n
=6
 m
ic
e.
Nutr Res. Author manuscript; available in PMC 2018 March 01.
